CN Patent

CN101356171A — 作为erbbi型受体酪氨酸激酶抑制剂用于治疗增殖性疾病的n4-苯基-喹唑啉-4-胺衍生物和相关化合物

Assigned to Array Biopharma Inc · Expires 2009-01-28 · 17y expired

What this patent protects

本发明提供式I的化合物，其中B、G、A、E、R 1 、R 2 、R 3 、m和n如本文中定义的，其可用作I型受体酪氨酸激酶抑制剂，并且提供了其在治疗哺乳动物的过度增殖性疾病中的使用方法。

USPTO Abstract

本发明提供式I的化合物，其中B、G、A、E、R 1 、R 2 、R 3 、m和n如本文中定义的，其可用作I型受体酪氨酸激酶抑制剂，并且提供了其在治疗哺乳动物的过度增殖性疾病中的使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101356171A
Jurisdiction
CN
Classification
—
Expires
2009-01-28
Drug substance claim
No
Drug product claim
No
Assignee
Array Biopharma Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.